More on INMB

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.4 Score)

Upcoming Events

- Earnings (8/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

INmune Bio (NQ:INMB)
Delayed: 1.62 -0.1 (5.81%)
Prev. Close $1.72  
Open$1.69 
52 Wk High$ 
52 Wk Low$ 
Day High$1.71 
Day Low$1.61 
P/E N/A  
EPS$ 
Volume186,099 


Jul 20, 2026 07:00 AM INmune Bio Completes Commercial Manufacturing Milestone Supporting Planned Global Registration Filings for CORDStrom™ Platform
Jul 15, 2026 07:01 AM INmune Bio publishes preclinical study on XPro1595 and brain injury
Jul 15, 2026 07:00 AM INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study
Jul 15, 2026 07:00 AM INmune Bio’s XPro1595 Prevents Brain-Injury-Induced Alzheimer's Pathology, Memory Loss, and Pain in New Peer-Reviewed Preclinical Study
Jul 9, 2026 07:00 AM INmune Bio to present Phase 2 imaging data for XPro at AAIC 2026
Jul 9, 2026 07:00 AM INmune Bio to Present Positive Phase 2 Imaging Data for XPro in Early Alzheimer’s Disease at AAIC
Jul 7, 2026 07:02 AM Form 4 Inmune Bio, Inc. For: Jul 02 Filed by: Juda Scott
Jul 7, 2026 07:01 AM Form 4 Inmune Bio, Inc. For: Jul 02 Filed by: Lowdell Mark William
Jul 7, 2026 07:00 AM Form 4 Inmune Bio, Inc. For: Jul 02 Filed by: Moss David J
Jul 1, 2026 07:16 AM Form 8-K Inmune Bio, Inc. For: Jun 30
View All Articles

Entities mentioned with INMB

View All Entities